Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Pharmerging Market Report by Product (Pharmaceuticals, Healthcare), Indication (Lifestyle Diseases, Cancer and Autoimmune Diseases, Infectious Diseases, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Stores, and Others), and Country 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A3441
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pharmerging Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Pharmaceutical
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Patented Prescription Drugs
6.1.2.2 Generic Prescription Drugs
6.1.2.3 OTC Drugs
6.1.3 Market Forecast
6.2 Healthcare
6.2.1 Market Trends
6.2.2 Major Types
6.2.2.1 Medical Devices
6.2.2.2 Clinical Diagnosis
6.2.2.3 Others
6.2.3 Market Forecast
7 Market Breakup by Indication
7.1 Lifestyle Diseases
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cancer and Autoimmune Diseases
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Infectious Diseases
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Country
9.1 Tier I
9.1.1 China
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.2 Tier II
9.2.1 India
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Brazil
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 Russia
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Africa
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.3 Tier III
9.3.1 Argentina
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 Mexico
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 Poland
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Ukraine
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Turkey
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Saudi Arabia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Egypt
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.3.8 Algeria
9.3.8.1 Market Trends
9.3.8.2 Market Forecast
9.3.9 Nigeria
9.3.9.1 Market Trends
9.3.9.2 Market Forecast
9.3.10 Thailand
9.3.10.1 Market Trends
9.3.10.2 Market Forecast
9.3.11 Indonesia
9.3.11.1 Market Trends
9.3.11.2 Market Forecast
9.3.12 Pakistan
9.3.12.1 Market Trends
9.3.12.2 Market Forecast
9.3.13 Others
9.3.13.1 Market Trends
9.3.13.2 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Sanofi S.A.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Pfizer Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 AstraZeneca Plc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 GlaxoSmithKline Plc.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 F. Hoffmann-La Roche AG (Roche AG)
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Eli Lilly and Company
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Johnson & Johnson
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Abbott Laboratories
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Novartis AG
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Teva Pharmaceutical Limited
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financial
13.3.10.4 SWOT Analysis
List of Figures
Figure 1: Global: Pharmerging Market: Major Drivers and Challenges
Figure 2: Global: Pharmerging Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Pharmerging Market: Breakup by Product (in %), 2023
Figure 4: Global: Pharmerging Market: Breakup by Indication (in %), 2023
Figure 5: Global: Pharmerging Market: Breakup by Distribution Channel (in %), 2023
Figure 6: Global: Pharmerging Market: Breakup by Country (in %), 2023
Figure 7: Global: Pharmerging Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 8: Global: Pharmerging (Pharmaceuticals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Pharmerging (Pharmaceuticals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Pharmerging (Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Pharmerging (Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Pharmerging (Lifestyle Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Pharmerging (Lifestyle Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Pharmerging (Cancer and Autoimmune Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Pharmerging (Cancer and Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Pharmerging (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Pharmerging (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Pharmerging (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Pharmerging (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Pharmerging (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Pharmerging (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Pharmerging (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Pharmerging (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Pharmerging (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Pharmerging (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Pharmerging (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Pharmerging (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Tier I: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Tier I: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: China: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: China: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Tier II: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Tier II: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: India: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: India: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Brazil: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Brazil: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Russia: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Russia: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: South Africa: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: South Africa: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Tier III: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Tier III: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Argentina: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Argentina: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Mexico: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Mexico: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Poland: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Poland: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Ukraine: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Ukraine: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Turkey: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Turkey: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Saudi Arabia: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Saudi Arabia: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Egypt: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Egypt: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Algeria: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Algeria: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Nigeria: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Nigeria: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Thailand: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Thailand: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Indonesia: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Indonesia: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Pakistan: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Pakistan: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Pharmerging Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Pharmerging Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Global: Pharmerging Industry: SWOT Analysis
Figure 71: Global: Pharmerging Industry: Value Chain Analysis
Figure 72: Global: Pharmerging Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Pharmerging Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Pharmerging Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Pharmerging Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 4: Global: Pharmerging Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Pharmerging Market Forecast: Breakup by Country (in Million US$), 2024-2032
Table 6: Global: Pharmerging Market: Competitive Structure
Table 7: Global: Pharmerging Market: Key Players
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More
IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.
Read More
I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested
Read More
Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.
Read More
The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.
Read More
I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you
Read More
The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.
Read More
One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.
Read More
We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.
Read More
The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.
Read More
The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.
Read More
The report is excellent and has good amount of data and our team is extremely happy with the information provided.
Read More
Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.
Read More